Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests (Schedule of Non-Controlling Interests in Consolidated Entities) (Details)

v3.22.1
Non-Controlling Interests (Schedule of Non-Controlling Interests in Consolidated Entities) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Noncontrolling Interest [Line Items]      
NCI equity share $ 129,437   $ 217,326
Net loss attributable to non-controlling interests (33,718) $ (17,244) (100,123)
Non-controlling interests in consolidated entities 95,719   117,203
UR-1 Therapeutics, Inc [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share 423   (442)
Net loss attributable to non-controlling interests (315)   (1,353)
Non-controlling interests in consolidated entities $ 108   $ (1,795)
Non-controlling ownership 34.50%   34.50%
Aevitas [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (5,057)   $ (4,159)
Net loss attributable to non-controlling interests (190)   (901)
Non-controlling interests in consolidated entities $ (5,247)   $ (5,060)
Non-controlling ownership 45.90%   45.90%
Avenue [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ 3,286   $ 5,739
Net loss attributable to non-controlling interests (2,326)   (2,909)
Non-controlling interests in consolidated entities $ 960   $ 2,830
Non-controlling ownership 82.80%   82.00%
Baergic [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (2,086)   $ (2,047)
Net loss attributable to non-controlling interests (90)   (39)
Non-controlling interests in consolidated entities $ (2,176)   $ (2,086)
Non-controlling ownership 39.00%   39.00%
Cellvation [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (1,544)   $ (1,413)
Net loss attributable to non-controlling interests (74)   (131)
Non-controlling interests in consolidated entities $ (1,618)   $ (1,544)
Non-controlling ownership 21.70%   21.70%
Checkpoint [Member].      
Noncontrolling Interest [Line Items]      
NCI equity share $ 29,839   $ 63,464
Net loss attributable to non-controlling interests (13,603)   (39,226)
Non-controlling interests in consolidated entities $ 16,236   $ 24,238
Non-controlling ownership 80.30%   81.50%
Coronado SO [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (290)   $ (290)
Net loss attributable to non-controlling interests 0   0
Non-controlling interests in consolidated entities $ (290)   $ (290)
Non-controlling ownership 13.00%   13.00%
Cyprium [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (2,166)   $ (1,397)
Net loss attributable to non-controlling interests (260)   (807)
Non-controlling interests in consolidated entities $ (2,426)   $ (2,204)
Non-controlling ownership 29.00%   29.80%
Helocyte [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (5,529)   $ (5,440)
Net loss attributable to non-controlling interests (110)   (89)
Non-controlling interests in consolidated entities $ (5,639)   $ (5,529)
Non-controlling ownership 18.30%   18.30%
JMC [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ 19,120   $ 23,150
Net loss attributable to non-controlling interests (457)   (5,652)
Non-controlling interests in consolidated entities $ 18,663   $ 17,498
Non-controlling ownership 41.60%   41.60%
Mustang [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ 95,305   $ 141,527
Net loss attributable to non-controlling interests (16,181)   (48,518)
Non-controlling interests in consolidated entities $ 79,124   $ 93,009
Non-controlling ownership 81.30%   82.70%
Oncogenuity [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (1,124)   $ (627)
Net loss attributable to non-controlling interests (103)   (497)
Non-controlling interests in consolidated entities $ (1,227)   $ (1,124)
Non-controlling ownership 24.90%   24.90%
Tamid [Member]      
Noncontrolling Interest [Line Items]      
NCI equity share $ (740)   $ (739)
Net loss attributable to non-controlling interests (9)   (1)
Non-controlling interests in consolidated entities $ (749)   $ (740)
Non-controlling ownership 22.80%   22.80%